UBS Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $72.2K | Sell |
|
|||||
|
2023
Q4 | $40.2K | Buy |
|
|||||
|
2023
Q3 | $23.7K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $11.8K | Sell |
|
|||||
|
2022
Q4 | $23.8K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $47K | Buy |
|
|||||
|
2021
Q3 | $17K | Sell |
|
|||||
|
2021
Q2 | $98K | Sell |
|
|||||
|
2021
Q1 | $1.23M | Buy |
|
|||||
|
2020
Q4 | $554K | Buy |
|
|||||
|
2020
Q3 | $196K | Buy |
|
|||||
|
2020
Q2 | $189K | Sell |
|
|||||
|
2020
Q1 | $130K | Sell |
|
|||||
|
2019
Q4 | $492K | Buy |
|
|||||
|
2019
Q3 | $127K | Buy |
|
|||||
|
2019
Q2 | $18K | Buy |
|